Neurocrine Biosciences, Inc. (BIT:1NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	11,533	12,044	13,349	11,712	10,744	7,105
Market Cap Growth	-21.18%	-9.78%	13.98%	9.01%	51.23%	-2.96%
Enterprise Value	10,999	11,503	12,439	10,969	10,261	6,829
Last Close Price	114.50	120.35	-	-	-	-
PE Ratio	31.62	29.55	40.49	51.85	74.32	90.18
PS Ratio	5.04	4.94	5.87	6.86	7.71	7.13
PB Ratio	4.51	4.35	5.34	5.80	6.72	5.88
P/TBV Ratio	4.56	4.35	5.43	5.91	6.90	5.88
P/FCF Ratio	22.81	18.89	24.80	35.80	35.56	34.66
P/OCF Ratio	21.25	18.07	23.21	33.20	33.83	31.50
EV/Sales Ratio	4.88	4.72	5.47	6.43	7.37	6.85
EV/EBITDA Ratio	20.73	20.26	21.11	29.14	41.44	35.51
EV/EBIT Ratio	24.23	21.22	22.09	30.71	44.04	37.38
EV/FCF Ratio	21.76	18.04	23.11	33.53	33.96	33.32
Debt / Equity Ratio	0.13	0.13	0.19	0.19	0.15	0.32
Debt / EBITDA Ratio	0.57	0.57	0.76	0.99	0.94	1.88
Debt / FCF Ratio	0.56	0.56	0.89	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.33	-0.33	-0.22	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.60	-1.60	-0.95	-1.45	-2.74	-1.24
Net Debt / FCF Ratio	-1.42	-1.42	-1.04	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	0.82	0.82	15.99	16.48	14.85	11.71
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	9.53%	9.53%	10.46%	8.78%	7.01%	6.82%
Return on Invested Capital (ROIC)	18.95%	20.58%	22.51%	22.75%	17.26%	19.95%
Return on Capital Employed (ROCE)	16.40%	16.40%	18.20%	15.20%	13.60%	11.40%
Earnings Yield	3.16%	3.38%	2.47%	1.93%	1.35%	1.11%
FCF Yield	4.38%	5.29%	4.03%	2.79%	2.81%	2.89%
Buyback Yield / Dilution	1.30%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.